Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 8/20 | 0.57 |
| ▸ | CCKAR | P32238 | 5/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9038942 | 0.92 | CCKBR (0.59) | CCKBRCCKAR | |
| SCHEMBL9038983 | 0.91 | CCKBR (0.64) | CCKBRCCKAR | |
| SCHEMBL9040039 | 0.90 | CCKBR (0.61) | CCKBRCCKAR | |
| SCHEMBL9041020 | 0.90 | CCKBR (0.54) | CCKBRCCKAR | |
| SCHEMBL9038776 | 0.90 | CCKAR (0.57) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL9040062 | 0.90 | CCKBR (0.62) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL9040863 | 0.89 | CCKBR (0.61) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL9040430 | 0.87 | CCKBR (0.51) | CCKBRCCKAR | |
| SCHEMBL4624938 | 0.86 | CYP3A4 (0.71) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL9039704 | 0.85 | CCKBR (0.60) | CCKBRCCKARCYP3A4MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0703222-A1 | 3-AMINOAZEPINE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-03-27 | — | — | EP | claimed |
| EP-0703222-A1 | 3-AMINOAZEPINE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-03-27 | — | — | EP | disclosed |